Plaquenil and Drooling - a phase IV clinical study of FDA data

Summary:

Drooling is reported as a side effect among people who take Plaquenil (hydroxychloroquine sulfate), especially for people who are female, 60+ old, also take Xeljanz, and have Muscle spasms.

The phase IV clinical study analyzes which people have Drooling when taking Plaquenil. It is created by eHealthMe based on reports of 88,348 people who have side effects when taking Plaquenil from the FDA, and is updated regularly.

What is Plaquenil?

Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 91,018 Plaquenil users. Check the latest studies of Plaquenil.

What is Drooling?

Drooling (drop saliva uncontrollably from the mouth) is found to be associated with 497 drugs and 941 conditions by eHealthMe. Check the latest studies of Drooling.

On Jul, 19, 2026

88,348 people reported to have side effects when taking Plaquenil.
Among them, 14 people (0.02%) have Drooling.

Among these 14 people:

What is the gender of people who have Drooling when taking Plaquenil? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Drooling when taking Plaquenil? *

What are other drugs people take besides Plaquenil? *

Xeljanz: 6 people, 42.86%
Vitamin D3: 5 people, 35.71%
Quinine: 5 people, 35.71%
Bisoprolol Fumarate: 4 people, 28.57%
Percocet: 4 people, 28.57%
Meloxicam: 4 people, 28.57%
Methotrexate Sodium: 4 people, 28.57%
Naltrexone Hydrochloride: 4 people, 28.57%
Breo Ellipta: 4 people, 28.57%
Kesimpta: 4 people, 28.57%

What are other side effects people have besides Drooling? *

Fatigue (feeling of tiredness): 11 people, 78.57%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 64.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 50.00%
Taste - Impaired: 7 people, 50.00%
Rhinorrhea (watery mucus discharge from the nose): 6 people, 42.86%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 42.86%
Nosebleed (bleeding from nose): 6 people, 42.86%
Peripheral Swelling: 6 people, 42.86%
Lower Respiratory Tract Infection: 6 people, 42.86%
Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances)): 6 people, 42.86%

What are the existing conditions these people have? *

Muscle Spasms (muscle contraction): 6 people, 42.86%
Pain In Extremity: 5 people, 35.71%
Pain: 5 people, 35.71%
High Blood Cholesterol: 5 people, 35.71%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 28.57%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 28.57%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 28.57%
Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 4 people, 28.57%
Stress And Anxiety: 1 person, 7.14%
Sleep Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Plaquenil and have Drooling?

- Check whether Drooling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plaquenil:

Plaquenil (91,018 reports)

Drooling treatments and more:

Drooling (8,115 reports)

Browse all side effects of Plaquenil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drooling:

Drooling (497 drugs)

Browse all the conditions that are associated with Drooling:

Drooling (941 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxychloroquine sulfate (the active ingredients of Plaquenil) and Plaquenil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.